This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Fiorentina D’Amore appointed to lead Blockchain.com’s Malta and EU operations
She has over 25 years’ experience in finance.
‘Financial education must come before distribution,’ Money Coach says in response to Budget 2026
He calls for a stronger national focus on financial education, arguing that new measures will only be truly effective if ...
Turning difficult conversations into growth opportunities
Leaning into discomfort to build trust, connection, and growth.
MCA CEO Jesmond Bugeja: ‘2024 was a landmark year’ as authority steps up digital oversight
The MCA took on broader responsibilities in digital services governance while continuing to steer the communications sector through evolving market ...
